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Abstract: Monosodium glutamate (MSG) is a food additive, commonly consumed as a flavor enhancer. 
However, both animal models and human clinical reports have established its harmful effects. This work was 
carried out to study the effects of monosodium glutamate on blood thrombocytes, coagulation and bleeding time 
in adult male rats. The rats were divided into four groups: group 1 serves as the control group; group 2 was 
treated with 13.28g/kg bw of MSG (0.88%); group 3 was treated with 6.64g/kg bw of MSG (0.44%); group 4 
was treated with 4.40g/kg bw of MSG (0.29%) for a period of 14 days respectively. Blood was taken via cardiac 
puncture for thrombocytes count, clotting and bleeding time were also taken. The results showed that there was 
a significant increase (p<0.05) in the number of platelets, bleeding time and clotting time in rats treated with 
13.28g/kg bw of MSG compared with their control counterpart which are indicative of thrombocytopenia and 
water retention. 
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I. Introduction 
Monosodium glutamate (MSG) is a food additive that acts as a preservative or as an enhancer of 
palatability and is locally called in Nigeria Ajinomoto. MSG is the sodium salt of non-essential amino acids in  
human foods. When present in free form, it has a flavor enhancing effect and for this reason it is added to foods 
as purified monosodium salt. In early 1900s scientists isolated the ingredient (glutamate) in plants that is the 
essential taste component responsible for the greatly enhancing flavor (1). Glutamate occurs naturally in 
virtually all foods, including meat, fish, poultry, breast milk and vegetables, with vegetables tending to contain 
proportionally higher levels of free glutamate (as MSG). Various processed and prepared foods such as 
traditional seasoning sauce and certain restaurant foods contain significant levels of free glutamate (as MSG), 
both from natural sources and from added monosodium glutamate (13,28). In the early part of the twentieth 
century, MSG was extracted from seaweed and other plant sources, today it is produced in many countries 
around the world through a natural fermentation process using molasses from sugar cane or sugar beets, as well 
as starch and corn sugar (17). However, in large quantities or amounts, it may cause chest pain, sensation of 
facial pressure, headaches, burning sensation, excessive fluid retention and sweating. Studies have shown that 
the body uses glutamate as a nerve impulse transmitter and that there are glutamate-responsive tissues all over 
the body and also used intravenously as an adjunct in the treatment of encephalopathy associated with hepatic 
disease (31). However, the safety of MSG usage has generated such controversial argument locally and 
internationally,(5). MSG has a toxic effect on the testes by causing a significant oligozoospermia and increased 
abnormal sperm morphology in a dose-dependent fashion in male wistar rats (26). It has been implicated in male 
infertility by causing testicular hemorrhage, degeneration and alteration of sperm cell population and 
morphology (25). Studies have also shown that Glutamate (MSG) causes reduction in the secretion of growth 
hormones, leading to stunted growth and irreversibility in obesity, excessive weight, essentially due to the 
accumulation of excess fats in adipose tissue (13,21,28 ), arising from high cholesterol levels leading to 
cardiovascular diseases and endocrinological disorder (13). The aim of this study was to investigate the effects 
of Monosodium Glutamate on platelet count, thrombocyte, coagulation and bleeding time in rats. 
 
II. Materials And Methods 
Experimental Animals 
Sixteen adult male wistar rats weighing between 140 and 200g were used for this study. The rats were 
obtained from the animal house, Bingham University, Karu, Nasarawa State, Nigeria and were acclimatized for 
a period of two weeks before the commencement of the study. They were randomly grouped and kept in clean 
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cages in a temperature-controlled romm with 12-hr light/dark schedule. They had access to rats chow and water 
was supplied ad-libitum.  
 
Acute Toxicity Test 
Acute toxicity study: Lethal dose (LD50) of monosodium glutamate was determined by the method of 
Lorke,(1), using 16 rats. In the first phase, rats were divided into four groups, containing two rats each and were 
treated with monosodium glutamate at doses of 2.5g/ml bw, 3.5g/ml bw, 4.0g/ml bw and 4.5g/ml bw were given 
by oral gavage. They were observed for twenty four hours for toxicity signs. In the second Phase, rats were 
divided into four groups, each group had two rats. They were treated at doses of 5.5g/ml bw, 10.5g/ml, 15.5g/ml 
and 16.5g/ml bw by oral gavage. The acute toxicity LD50 was calculated as the geometric mean of the dose that 
resulted in 100% mortality and that which caused no lethality at all. 
 
Preparation of Monosodium Glutamate 
Monosodium glutamate (MSG) was obtained from Mararaba market, Abuja, Nigeria for use in this 
study. A stock solution was prepared by dissolving MSG granules in 695 ml of distilled water, from this and 
based on the animal weight, 340.48g dosage was administered orally to the animals in the test groups 2, 3, and 
4. Group one served as the control group; group two received 13.28g/ml bw of MSG; group three received 
6.64g/ml bw of MSG; while group four had 4.40g/ml bw of MSG for 14 days respectively. 
 
Blood Collection 
At the end of monosodium glutamate treatment, the rats were anesthetized with diethyl ether and blood 
samples were collected via cardiac puncture into EDTA bottles for hematological indices. 
 
Blood Thrombocytes count 
The Rees Ecker’s method was applied for blood thrombocyte count. The number of platelets was 
calculated per µL (x 109L)0f blood. The average number of platelets counted on both sides of the counting 
chamber was multiplied by 1000 to get the total platelet count/mm3 (6). 
 
Blood Coagulation 
The rats tails were warmed for one minute at 400C, the tails were dried and cut at the tip with a sterile 
razor. The blood samples collected were kept in silicon glass test tubes. The glass test tubes were labeled 1, 2 
and 3 respectively. About 1 to 2ml of blood were placed in each of the three glass test tubes. However, the stop 
watch was started as soon as blood enters the tubes. All tubes were placed in 370C water bath and the tube 
labeled three was tilted gently at an angle of 45 for every 30 seconds until the blood clots. Also, tube labeled 
two was done in like manner until the blood was allowed to clot. Tube labeled one was tilted until no blood flow 
was observed on tilting. The time taken was recorded. The coagulation time was the time required for blood to 
clot in the last tube (tube labeled one), (34). 
 
Bleeding 
The rats tails were sterilized and were warmed for 1 minutes in water bath at 400C and then dried. This 
was measured by cutting the tail-tip (33) with a sterile lancet. A stop watch was started immediately. Blood was 
blotted every 30 seconds using Whitman filter paper until bleeding ceased. The time taken for the blood to stop 
flowing was recorded as the bleeding time, (22). 
 
Statistical analysis 
The data were expressed as mean ± SEM. Readings within a group were compared using the one-way 
ANOVA analysis and readings between groups were compared using the Independent sample test. Statistical 
analysis was performed using SPSS (Version 17). A level of p <0.05 was considered to be significant. 
  
III. Results 
Table-1. Toxicity effects of monosodium glutamate in male adult rats. 
Group Dose (g/ml)bw No of Death % mortality 
1 5.5 0 0 
2 10.5 0 0 
3 15.5 0 0 
4 16.5 2 100 
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The results in table 1 showed that monosodium glutamate was toxic at a concentration of 16.5g/ml in which 
there was a percentage mortality of 100 (%). However, no mortality was observed in groups treated with 5.5, 
10.5, and 15.5g/ml bw of monosodium glutamate given orally after a period of 24 hours. Hence, the LD50 was 
taken to be 16.5g/ml. 
 
Table-2.  Effects of monosodium glutamate on body weight and Platelet Count 
Group Weight(g) Platelet count (mm
3
) 
Control (distilled water) 149.4±1.43 319,250 
Group2 (13.28g/ml) 154.7±1.18 683,750* 
Group3 (6.64g/ml) 165.9±2.85* 405,000 
Group4 (4.40g/ml) 151.4±4.33 286,000 
   
The results in table two showed that there was a significant increase (p<0.05) in mean body weight of groups 3 
treated with 6.64g/ml monosodium glutamate when compared with the control group. However, there was 
significant difference (p<0.05) in platelet values of groups 2 and 3. 
 
Table-3. Effects of monosodium on bleeding time 
Group Bleeding time (sec) 
Group1 (control) 330.6 ±14.08 
Group 2 555.9 ±22.59* 
Group 3 345.0 ±15.70 
Group 4 189.1 ±21.77 
 
There was a significant increase (p<0.05) in bleeding time value of group 2 treated rats when compared with the 
control. There was an insignificant difference (p>0.05) in bleeding time of group 3 treated rats when compared 
with the control group. However, there was a significant decrease (p<0.05) in bleeding time of group 4 treated 
rats when compared with the control group. 
 
Table-4. Effects of monosodium glutamate on clotting time 
Group Clotting time(sec) 
Control 241.0±10.54 
Group2 374.8±22.74* 
Group3 251.8±22.84 
Group4 147.1±14.10 
 
There was a significant increase (p<0.05) in the mean clotting time of group 2 treated rats when 
compared with their control counterpart. However, there was an insignificant difference (p>0.05) in group 3 
treated rats when compared with the control group. There was a significant decrease (p<0.05) in group 4 treated 
rats when compared with the control counterpart. 
 
IV. Discussion 
Hemostasis has been divided into vascular/platelet phase and coagulation phase, the tests available for 
the first phase are bleeding time, platelet count and platelet function assay (11). However, the tests available to 
test the coagulation phase of hemostasis are whole blood clotting time, prothrombin time, activated plasma 
thromboplastin time, thrombin time. The bleeding time is affected by large number of diseases, drugs, 
physiologic factors, test conditions, and therapeutic actions, not all of the above mentioned are platelet related 
(12). However, the results in this study showed that Monosodiun glutamate (MSG) significantly increased the 
platelet cell counts of rats treated with high concentration of 13.28g/ml MSG for 14 days consecutively. There 
was also a significant increase in the platelet cell count of rats treated with 6.64g/ml MSG for 14 days as shown 
in table 4 above. This indicates that high concentration of MSG treatment may seems to lead to an increased 
number of platelet cell in the blood known as thrombocytosis or thrombocythemia. It was also suggested that the 
increase might be due to the excessive intake of one of MSG component which includes sodium and glutamate 
that affect blood and body fluid compartments and water balance of the body. However, the mechanism of 
action of Monosodium glutamate by altering the platelet cells, in the body is yet to be fully elucidated. The 
hormone, called Thrombopoietin, stimulates the production of platelets, which promote blood clotting. Its 
discovery is expected to benefit cancer or lymphoma patients who have received chemotherapy or a bone 
marrow transplant. These patients have low platelet counts, putting them at serious risk of death from bleeding. 
Currently they are treated with transfusion of platelets, which requires time-consuming procedures and many 
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blood donors. Thrombopoietin seems able to increase platelets to previously unattainable levels. 
Thrombopoietin secreted by the kidneys and produces platelet cells. However, with renal failure there is a 
decrease in production of this hormone and thrombocytopenia results. The results in this study suggest that 
administration of MSG for 14 days at a dose of 4.40g/ml did not cause an increase in platelet cell count but 
caused a decrease in platelet count and this may be dose dependent. Also, the result in this study shows that 
bleeding and clotting time were increased following administration of Monosodium glutamate at doses of 
13.28g/ml and 6.64g/ml for 14 days which may be as a result of water retension in the fluid compartments of 
rats treated with high dose of MSG. In conclusion, it was observed from this study that Monosodium glutamate 
has a significant effects on the platelet count which may be indicative of thrombocythemic conditions in the 
treated rats. Hence, these findings support the fact that Monosodium glutamate taken in excess despite its 
flavouring functions is detrimental to health (14). 
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